LINDSTROM RICHARD L MD

LINDSTROM RICHARD L MD serves as Director at Harrow Health, Inc. (HROW). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$69.6K

Total Sells

5 trades

$975.8K

Net Position

Net Seller

$906.2K

Companies Traded

2

OCUL, HROW

Active Period

May 2021 – May 2025

6 total trades

Most Recent

Buy OCUL

May 12, 2025 · $69.6K

LINDSTROM RICHARD L MD's Insider Trading at Harrow Health, Inc. (HROW)

Buys

0 · $0.00

Sells

4 · $832.8K

Total Shares Bought

0

Total Shares Sold

73,900

HROW Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 3, 2022	Sell	40,000	$12.62	$504.8K	26,100
Sep 27, 2021	Sell	3,900	$10.04	$39.2K	66,100
Sep 17, 2021	Sell	20,000	$9.07	$181.4K	75,840
May 21, 2021	Sell	10,000	$10.75	$107.5K	90,000

LINDSTROM RICHARD L MD's Insider Trading at Ocular Therapeutix, Inc. (OCUL)

Buys

1 · $69.6K

Sells

1 · $143.0K

Total Shares Bought

10,000

Total Shares Sold

10,000

OCUL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 12, 2025	Buy	10,000	$6.96	$69.6K	172,704
May 21, 2021	Sell	10,000	$14.30	$143.0K	90,000

Related Insiders

Nadia Waheed

officer: Chief Medical Officer

OCULSell · Jun 5, 2026

Peter Kaiser

officer: Chief Development Officer

OCULSell · May 28, 2026

Pravin Dugel

See Remarks

OCULSell · May 28, 2026

Jeffrey S. Heier

officer: Chief Scientific Officer

OCULSell · May 28, 2026

Sanjay Nayak

officer: Chief Strategy Officer

OCULSell · May 28, 2026

SILVERNAIL LAUREN P

director

HROWBuy · May 19, 2026

Adrienne L Graves

director

HROWBuy · May 19, 2026

BAUM MARK L

director, officer: CHIEF EXECUTIVE OFFICER

HROWBuy · May 15, 2026

Explore More Insider Trading Data

HROW Insider Trading Activity

View all insider trades at Harrow Health, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity